CASI Pharmaceuticals, Inc. (CASI)

CASI Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	73	96	24	112	366	298
Market Cap Growth	293.30%	293.30%	-78.22%	-69.41%	22.82%	-20.87%
Enterprise Value	61	84	-27	63	301	243
PE Ratio	-	-3.55	-0.59	-3.05	-7.57	-6.47
PS Ratio	2.14	2.83	0.56	3.71	24.15	72.07
PB Ratio	3.00	3.96	0.55	1.32	4.48	4.08
P/FCF Ratio	-4.31	-4.31	-0.92	-3.13	-14.81	-9.83
P/OCF Ratio	-4.80	-4.80	-1.15	-4.17	-14.12	-12.81
EV/Sales Ratio	1.79	2.48	-0.63	2.10	19.85	58.94
EV/EBITDA Ratio	-3.76	-3.76	0.76	-1.89	-6.67	-5.60
EV/EBIT Ratio	-3.11	-3.11	0.69	-1.73	-6.22	-5.29
EV/FCF Ratio	-3.78	-3.78	1.02	-1.77	-12.18	-8.04
Debt / Equity Ratio	0.78	0.78	-	-	0.02	-
Debt / EBITDA Ratio	-0.85	-0.85	-	-	-0.03	-
Debt / FCF Ratio	-0.85	-0.85	-	-	-0.05	-
Quick Ratio	2.45	2.45	3.78	4.43	8.90	6.99
Current Ratio	3.55	3.55	4.32	4.70	9.28	8.14
Asset Turnover	0.43	0.43	0.37	0.21	0.13	0.04
Return on Equity (ROE)	-86.40%	-86.40%	-66.10%	-40.10%	-63.00%	-53.10%
Return on Assets (ROA)	-34.20%	-34.20%	-34.70%	-25.80%	-42.60%	-40.00%
Return on Capital (ROIC)	-58.71%	-58.71%	-83.62%	-49.51%	-62.21%	-64.33%
Earnings Yield	-37.19%	-28.15%	-168.40%	-32.77%	-13.21%	-15.46%
FCF Yield	-30.63%	-23.18%	-109.06%	-31.99%	-6.75%	-10.18%
Buyback Yield / Dilution	2.10%	2.10%	-0.27%	-23.23%	-15.12%	-13.21%
Total Shareholder Return	2.10%	2.10%	-0.27%	-23.23%	-15.12%	-13.21%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).